// App-Quantinova.ai

LBA4 : Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION).

Researchers

Presenter

  • Michael J. Morris

Principal Investigators

  • Kim N. Chi

  • Karim Fizazi

  • Ken Herrmann

  • Kambiz Rahbar

  • Scott T. Tagawa

  • Luke T. Nordquist

  • Nitin Vaishampayan

  • Ghassan El-Haddad

  • Chandler H. Park

  • Tomasz M. Beer

  • Wendy J Prez-Contreras

  • Michelle Desilvio

  • Euloge E. Kpamegan

  • Germo Gericke

  • Richard Adam Messmann

  • Bernd J. Krause

  • A. Oliver Sartor

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • The Institute of Cancer Research & The Royal Marsden, London, Spain

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Canada.

  • Gustave Roussy Institute, Paris-Saclay University, Villejuif, France

  • University Hospital of Essen, Essen, Germany

  • University Hospital of Muenster, Muenster, Germany

  • Weill Cornell Medicine, New York, NY

  • Urology Cancer Center, Omaha, NE

  • Department of Statistics, Wayne State University, Detroit, MI

  • Moffitt Cancer Ctr Univ of S Florida, Tampa, FL

  • Norton Cancer Institute, Louisville, KY

  • Knight Cancer Institute, Oregon Health and Science University, Portland, OR

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Novartis AG, Basel, Switzerland

  • Department of Ophthalmology, Rostock University Medical Center, Rostock, Germany

  • Tulane University School of Medicine, New Orleans, LA

Locations

  • United States

  • United Kingdom

  • Canada

  • France

  • Germany

  • Switzerland

Companies

  • Novartis AG

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Radium-223 Dichloride

  • Androgen Tear

  • taxane

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multinational

Phase

  • III

Study Id's

  • NCT03511664

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved